Oppenheimer analyst issues OUTPERFORM recommendation for CRWD on July 19, 2024 07:48AM ET. The previous analyst recommendation was Outperform.CRWD was trading at $343.05 at issue of the analyst recommendation.The overall...
BTIG analyst issues BUY recommendation for ISRG on July 19, 2024 07:25AM ET. The previous analyst recommendation was Buy.ISRG was trading at $416.14 at issue of the analyst recommendation.The overall...
Morgan Stanley analyst issues OVERWEIGHT recommendation for ARM on July 19, 2024 04:39AM ET. ARM was trading at $158.33 at issue of the analyst recommendation.The overall analyst consensus : BUY.Current...
Oppenheimer analyst issues OUTPERFORM recommendation for META on July 19, 2024 05:17AM ET. The previous analyst recommendation was Outperform.META was trading at $475.85 at issue of the analyst recommendation.The overall...
Wedbush analyst issues OUTPERFORM recommendation for PLTR on July 18, 2024 08:20AM ET. The previous analyst recommendation was Outperform.PLTR was trading at $28.905 at issue of the analyst recommendation.The overall...
Morgan Stanley analyst issues OVERWEIGHT recommendation for ANET on July 18, 2024 09:34AM ET. The previous analyst recommendation was Overweight.ANET was trading at $337.405 at issue of the analyst recommendation.The...
Cowen & Co. analyst issues BUY recommendation for MSFT on July 18, 2024 05:55AM ET. The previous analyst recommendation was Buy.MSFT was trading at $443.52 at issue of the analyst...
Barclays analyst issues OVERWEIGHT recommendation for ISRG on July 18, 2024 06:08AM ET. The previous analyst recommendation was Overweight.ISRG was trading at $426.23 at issue of the analyst recommendation.The overall...
Scotiabank analyst issues UNDERPERFORM recommendation for CRWD on July 17, 2024 02:00PM ET. The previous analyst recommendation was Underperform.CRWD was trading at $354.94 at issue of the analyst recommendation.The overall...
Wedbush analyst issues BUY recommendation for CRWD on July 17, 2024 02:00PM ET. The previous analyst recommendation was Buy.CRWD was trading at $354.94 at issue of the analyst recommendation.The overall...
